ins. Disease recognition has increased because of heightened awareness among primary and tertiary care providers, efforts from patient advocacy groups and novel research studies.
History
A short time ago, eosinophilic esophagitis (EoE) was thought to be merely a clinical curiosity, but now an increasing body of clinical and research experience has identified EoE as a well-defined clinicopathological disease [1] . In 1993 and 1994, the first two comprehensive descriptions of this disease arose from clinical series of adults who presented with dysphagia and esophageal eosinophilia, but who did not have gastroesophageal reflux as a cause [2, 3] . In 1995, a group of 10 children with GERD-like symptoms, esophageal eosinophilia and normal pH monitoring were reported to respond to an elemental formula diet [4] . In 1998, two studies described children who had GERD-like symptoms and esophageal mucosal biopsies that demonstrated 1 20 eosinophils per high-power field (HPF) [5, 6] . Biopsies of the stomach and duodenum were normal and the patients had normal esophageal pH monitoring. They were not responsive to antiacid treatment, but were responsive to systemic corticosteroids or an elemental formula diet. Over the course of the next 8 years, a number of studies of adults and chil-
Introduction
During the last 5 years, there has been a remarkable increase in the incidence and recognition of the newest esophageal inflammatory disease, termed eosinophilic esophagitis. This increase follows the atopic march of other allergic lung and skin diseases. The reasons for this rise are uncertain, but speculations include the hygiene hypothesis, antiacid use, new allergen exposures and tox- dren began to provide more descriptive elements of these patients, but diagnostic criteria became less and less clear. This ambiguity was best enunciated in 2007 when it was noted that a third of the published literature focusing on EoE did not even list the number of eosinophils in the squamous epithelium [7] . In addition, studies rarely stated the size of the HPF used to document the numbers of eosinophils, a problem that led to significant disparity in enumerations.
In an attempt to address these diagnostic issues, a multidisciplinary group of adult and pediatric gastroenterologists, allergologists, immunologists and histopathologists gathered (First International Gastrointestinal Eosinophil Research Symposium), reviewed the available literature and used clinical expertise to set forth a working definition/diagnostic criteria for EoE (slide set www. naspghan.org) [1] . Based on this group's work, EoE was defined as a clinicopathological disease requiring clinical symptoms and isolated esophageal eosinophilia manifested by 15 or more intraepithelial eosinophils in the most densely involved high-power microscopic field (400 ! magnification). GERD and other etiologies for esophageal inflammation must be ruled out as potential causes for esophageal eosinophilia, while gastric and duodenal mucosal biopsies must be normal. Multiple acronyms have been used for this disease, but because of confusion with erosive esophagitis (EE), gastroenterologists typically refer to eosinophilic esophagitis as EoE.
Clinical Presentation
For unknown reasons, male gender accounts for over 75% of patients with EoE. EoE has been reported in all age groups and on all continents except Africa. The overall incidence is not known, but estimates range from 1-4 per 10,000 [8] [9] [10] .
Symptoms in children with EoE can be characterized by three distinct clinical patterns [1, [11] [12] [13] . Feeding dysfunction may be the only symptom of infants or toddlers. GERD-like symptoms such as vomiting, regurgitation, water brash, epigastric abdominal pain, heartburn or chest pain are the second mode of presentation. Finally, teenagers and adults may present with intermittent or chronic dysphagia, or acute food impaction. Heightened awareness for the diagnosis of EoE should be given to any patient with any of these symptoms, especially when symptoms are recurrent and/or recalcitrant to treatment of GERD with either proton pump inhibition or Nissen fundoplication.
The etiology of esophageal food impaction due to EoE is not certain, but can occur secondary to a fixed anatomical stricture, mucosal edema or intermittent esophageal spasm. A number of studies of adults suggest that EoE is a common cause of esophageal food impaction, especially when recurrent [14] [15] [16] [17] [18] . For instance, Desai et al. [15] reported that 17 of 31 adult patients presenting with an acute esophageal food impaction had 1 20 eosinophils per HPF.
Natural History
The only documented long-term complication associated with EoE is an isolated stricture or long segment esophageal narrowing [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] . Numerous reports of children and adults report the finding of isolated strictures, in particular proximal strictures, in patients with EoE. In addition, diffuse and long segment narrowing has been associated with older children and adults. This finding probably represents long-standing inflammation that leads to a fragile mucosa, sometimes termed 'crêpe paper' mucosa. The passage of the endoscope may result in longitudinal splitting of the esophageal mucosa, a lengthy and frightening rent or tear. While typically not a full thickness defect, this lesion often results in severe pain that may require hospitalization.
Esophageal cancer has not been identified in patients with EoE, but several case reports and abstracts suggest an association with Barrett's esophagus [32] [33] [34] . Whether this association is valid or represents a distinct subset of adults with GERD and esophageal eosinophilia is not yet certain. While feeding dysfunction may be a primary symptom of young children with EoE, it may also persist despite resolution of esophageal inflammation [35] .
Radiology
A number of early case reports identified radiological features of EoE. For instance, in 1981, a 16-year-old boy with an 18-month history of increasing dysphagia and peripheral eosinophilia was found to have an esophageal polyp and a 6-cm narrowing of the proximal and midesophagus on a barium swallow [36] . Mucosal biopsy of the esophageal epithelium demonstrated large numbers of eosinophils. Treatment with systemic steroids improved the symptoms, but a post-inflammatory, proximal stricture remained. Others have reported long, irregular, proximal, middle or distal strictures and esopha- geal polyps [29, 31, 37] . Another radiological clue to the diagnosis of EoE is the Schatzki ring [38] . While the radiological finding is typically thought to be either peptic or congenital in origin, one study noted that the Schatzki ring may represent a transient contraction of the distal esophagus.
Endoscopy
EoE has been characterized by a number of mucosal irregularities including: longitudinal linear furrows, or vertical lines of the esophageal mucosa; concentric rings (trachealization); whitish exudates, or papules on the esophageal surface; longitudinal rents in a fragile esophageal mucosa; 'crêpe paper' esophagus; small caliber esophagus; esophageal strictures; and normal-looking mucosa [39] .
The whitish exudate may take on speckled, granular or papular patterns. This feature has been mistaken for candidal infection, but has now been recognized as an exudate rich in eosinophils in at least two studies [40, 41] . Small-caliber esophagus and the 'crêpe paper' or fragile esophageal mucosa have only been described in association with EoE and may represent the only pathognomonic feature. A small-caliber esophagus is most apparent on a barium swallow, which demonstrates absent esophageal contractions and diminished distensibility that can extend along any length of the esophagus [28, [42] [43] [44] [45] . A 'crêpe paper' or fragile esophageal mucosa refers to a longitudinal rent that is seen during the removal of the endoscope. The depth of this tear is variable, but is typically superficial. Esophageal strictures, particularly proximal strictures, are now recognized to be strongly associated with EoE [23, 27, 38, 46] . Multiple concentric rings are mistaken for congenital esophageal rings, or described as 'feline esophagus', or esophageal trachealization [47, 48] . In contrast to GERD, ulceration is distinctly uncommon in EoE [49] . Instead, the mucosa often reveals a rubbery texture that can be difficult to biopsy.
Histopathology
Histological patterns associated with EoE are a source of recent controversy. Few, diseases are histologically defined by a single cell number; the characterization of EoE as having 1 15-20 eosinophils per HPF is therefore less than satisfying [50] [51] [52] . Recent evidence and discussion have focused on the fact that the histological finding of esophageal eosinophilia must be interpreted in the clinical context in which it was obtained because this pattern of inflammation carries a lengthy differential diagnosis that includes GERD, celiac disease, Crohn's disease, infection, hypersensitivity responses, connective tissue disease and cancer [53] . For instance, Ngo et al. [54] described 3 patients with clinicopathological features consistent with EoE, which included large numbers of eosinophils in the squamous epithelium and one patient with whitish exudates. After treatment with proton pump inhibition, the white exudates and eosinophilia resolved in all three, suggesting that peptic disease was the etiological agent for these findings. Histological features of EoE in adult patients are similar to those observed in children [53] .
Considerable effort was spent at the First International Gastrointestinal Eosinophilic Research Symposium to define the threshold number of eosinophils per HPF that characterized EoE [1] . Despite the variability in the literature regarding the number of intraepithelial eosinophils used to make the diagnosis of EoE, the number of 1 15 eosinophils per HPF was agreed upon in order to capture the majority of patients with suspected EoE. It is critical to remember that this number must be interpreted in the context of the clinical setting in which the biopsies were obtained. The diagnosis must have excluded other etiologies for the eosinophilic inflammation [1, 55] .
The mucosal eosinophilia associated with EoE ranges from just 15 to hundreds of eosinophils per HPF. Other features include eosinophilic microabscesses, superficial layering of eosinophils along the luminal epithelium and eosinophil degranulation [15, [56] [57] [58] [59] . Using both a novel antibody for eosinophil peroxidase and scoring system, Protheroe et al. [60] was able to discriminate the histopathology of GERD from EoE. Basal cell hyperplasia, elongation of the rete papillae and dilated intercellular spaces have all been described in EoE. Associated inflammatory cells also include lymphocytes and mast cells [61] [62] [63] [64] [65] .
Two studies have attempted to define the number of esophageal biopsies necessary to make a diagnosis of EoE [66, 67] . Studies have determined that four and five random biopsies of the esophageal mucosa are optimal in children and adults, respectively. If there is a high index of suspicion for EoE, but the threshold number of 1 15 eosinophils per HPF is not reached, the fact that EoE may be a patchy disease (and missed on biopsy) should be considered as well as that eosinophils may have undergone massive degranulation, leaving no intact eosinophils present in the mucosa. Other technical issues deserve comment until histological analysis is standardized. Quantification of eosinophils per HPF depends on the numbers of HPFs counted, the surface area used for an individual HPF and the method for characterizing eosinophils.
Pathophysiology
A family history of EoE has been recognized, implicating the role of genetics. Seventeen patients from 7 families with dysphagia and gastrointestinal eosinophilia have been reported [68] . Of these, 12 patients were shown to have EoE. Three brothers with intermittent dysphagia and 20-40 eosinophils per HPF in the esophageal epithelium have been reported [69] .
In a landmark report, Blanchard et al. [70] hypothesized that EoE patients had a specific genetic profile. Microarray analysis of tissues from EoE patients identified a unique EoE gene signature, with eotaxin-3 being the most upregulated gene. Recent studies support a role for IL-13 [71] , while translational studies have shown that esophageal eosinophils express increased IL-4 and IL-13 compared to normal controls [72] . Furthermore, esophageal mRNA expression from children with EoE expresses more IFN-␥ , eotaxin-1 and IL-5 than normal tissue [73] .
Treatment
Treatment should eliminate symptoms, prevent disease sequelae and allow for easy compliance in a cost-effective manner. This is not necessarily easy to achieve for EoE. Long-term use of corticosteroids may lead to side effects, while nutritional therapy can be difficult, costly and associated with poor compliance. Furthermore, treatment endpoints and disease sequelae are uncertain. Thus, approaches to treatment should be individualized and discussed at length with patients. For a brief synopsis of treatment options, there are a number of recent excellent reviews for more detailed consideration [74] [75] [76] .
Nutritional Management
Food allergens are frequently associated with eosinophilic inflammation [77] [78] [79] . This has led to treatment with an amino acid-based formula, removal of specific foods based on allergy testing or empirical restriction of common allergenic foods. All approaches have been shown to be effective in treating children with EoE [4] . Kelly et al. [4] demonstrated that 10 children who underwent 10 weeks of treatment with an amino acid-based formula developed clinicopathological remission. In other studies, with larger numbers of patients, more than 92% of children treated with nutritional therapy successfully achieved and then maintained remission [77] [78] [79] . The high expense and unsatisfactory taste of liquid formula diets are inevitably associated with poor compliance with this approach.
Traditional testing methods for food sensitivity include RAST testing and IgE skin prick tests; however, these have doubtful predictive value for identifying food antigens responsible for eosinophilic esophageal inflammation. Atopy patch tests might also be useful for identifying potential allergens [80] . The elimination of the six most common food allergens (eggs, soya, dairy, wheat, peanuts, fish and shellfish) has served as another approach to EoE treatment [81] . This treatment led to 74% of children achieving clinicopathological remission.
Corticosteroids
Systemic corticosteroids induce clinicopathological remission in children with EoE [82] . An attractive alternative to systemic steroids are topical corticosteroids delivered from a metered dose inhaler [83] . The metered dose inhaler is sprayed in the mouth without a spacer and the mouth is not rinsed after use. Since the swallowed dose undergoes rapid hepatic metabolism, the side effects should be minimal. This technique has now been reported to be successful in multiple case series and in one double-blind placebo-controlled trial [65, [84] [85] [86] [87] [88] . To provide easier delivery of topical steroids to children, a viscous preparation of budesonide has been reported to be successful [89, 90] . The main reported side effect of this topical steroids is oral and esophageal candidal infection.
Esophageal Dilatation
Mechanical dilatation may be needed for a stricture or narrow caliber esophagus [25, 26, 28, 44, 45, [91] [92] [93] [94] . Dilatation should be attempted cautiously and without the same vigor as peptic strictures. Dilatation may be required in sequential sessions. Severe chest pain may require overnight hospitalization, but perforation is exceptional.
Novel Biological Therapy
Studies support the use of monoclonal antibodies such as anti-IL-5 in the treatment of EoE [95, 96] . Two clinical reports describe positive outcomes in diminishing symptoms and improving histological abnormalities [97, 98] . Further clinical trials are presently underway. 
Summary
EoE has been recognized as a new inflammatory disease. Recognition of this disease relies on the clinician remembering that patients may present with GERD-like symptoms that are recalcitrant to medical and surgical management, food impaction or dysphagia. Histological features are nondescript but include dense esophageal eosinophilia, eosinophil degranulation and markers of esophageal injury. Endoscopic features suggest acute inflammation and chronic remodeling. Treatment includes nutritional restriction and use of corticosteroids. To date the pathophysiology is uncertain and remains a ripe area for research that will lead to identification of novel therapeutic targets. Collaborative, multi-disciplinary studies will provide answers to improve the quality of life of patients with EoE. 
